$BCRX News Article - Journal of Allergy and Clinical Immunology Publishes Results from BioCryst's APeX-2 Pivotal Trial of Oral, Once-Daily Berotralstat for the Prevention of HAE Attacks https://marketwirenews.com/news-releases/jour...27885.html
(0)
(0)
BioCryst Pharmaceuticals Inc. (BCRX) Stock Research Links